Home › Myotonic Dystrophy › Iowa
Myotonic Dystrophy clinical trials in Iowa
3 studies for Myotonic Dystrophy are looking for participants at sites in Iowa.
Cities in Iowa
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
- University of Iowa, Iowa City
RecruitingObservational study
Ages 18 to 70 · All sexes · Updated Jun 10, 2026 · NCT03981575Study of ATX-01 in Participants With DM1
- University of Iowa Health Care - Department of Neurology, Iowa City
RecruitingPhase 1/2
Ages 18 to 64 · All sexes · Updated Feb 10, 2026 · NCT06300307Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy
- University of Iowa Hospitals and Clinics, Iowa City
RecruitingPhase 2/3
Ages 6 to 45 · All sexes · Updated May 28, 2025 · NCT05004129From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.